Copyright
©The Author(s) 2016.
World J Gastrointest Oncol. Sep 15, 2016; 8(9): 695-706
Published online Sep 15, 2016. doi: 10.4251/wjgo.v8.i9.695
Published online Sep 15, 2016. doi: 10.4251/wjgo.v8.i9.695
Group I (n = 45) | Group II (n = 42) | Comparison of groups I and II | |||
Pre-treatment | Post-treatment | Pre-treatment | Post-treatment | P value | |
T stage | 0.17 | ||||
T0 | - | 9 (18.9) | - | 8 (19) | |
T1 | - | 2 (4.4) | - | 2 (4.8) | |
T2 | 8 (17.8) | 14 (31.7) | 6 (14.3) | 14 (33.4) | |
T3 | 28 (62.2) | 19 (42.8) | 32 (76.2) | 16 (38.1) | |
T4 | 9 (20) | 1 (2.2) | 4 (9.5) | 2 (4.8) | |
Stage | 0.002 | ||||
Stage 0 | - | 4 (8.9) | - | 8 (19) | |
Stage 1 | - | 11 (24.4) | - | 15 (35.7) | |
Stage 2 | 4 (8.9) | 8 (17.8) | 2 (11.9) | 11 (26.2) | |
Stage 3 | 41 (91.1) | 22 (48.9) | 37 (88.1) | 8 (19) | |
Postop LN without metastasis | 21 (46.7) | 34 (81) | 0.001 |
- Citation: Mihmanlı M, Kabul Gürbulak E, Akgün İE, Celayir MF, Yazıcı P, Tunçel D, Bek TT, Öz A, Ömeroğlu S. Delaying surgery after neoadjuvant chemoradiotherapy improves prognosis of rectal cancer. World J Gastrointest Oncol 2016; 8(9): 695-706
- URL: https://www.wjgnet.com/1948-5204/full/v8/i9/695.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v8.i9.695